{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:55:44Z","timestamp":1780498544317,"version":"3.54.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.det.2025.03.013","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T13:21:57Z","timestamp":1747228917000},"page":"495-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Radiation Therapy for Metastatic Melanoma"],"prefix":"10.1016","volume":"43","author":[{"given":"Lauren","family":"DeBusk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Burshtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milaan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Zakria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Bartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell","family":"Rigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.det.2025.03.013_bib1","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/life13030828","article-title":"Melanoma brain metastases: a systematic review of opportunities for earlier detection, diagnosis, and treatment","volume":"13","author":"Diaz","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.det.2025.03.013_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.det.2025.03.013_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/cancers3010126","article-title":"Decoding melanoma metastasis","volume":"3","author":"Damsky","year":"2010","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.det.2025.03.013_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.det.2012.04.011","article-title":"Radiation therapy for cutaneous melanoma","volume":"30","author":"Barker","year":"2012","journal-title":"Dermatol Clin"},{"issue":"6","key":"10.1016\/j.det.2025.03.013_bib5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/cncr.20092","article-title":"Estimation of an optimal radiotherapy utilization rate for melanoma: a review of the evidence","volume":"100","author":"Delaney","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.det.2025.03.013_bib6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2006.06.051","article-title":"How gender, age, and geography influence the utilization of radiation therapy in the management of malignant melanoma","volume":"66","author":"French","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.det.2025.03.013_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clon.2009.07.003","article-title":"Radiotherapy in England in 2007: modelled demand and audited activity","volume":"21","author":"Williams","year":"2009","journal-title":"Clin Oncol"},{"issue":"4","key":"10.1016\/j.det.2025.03.013_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0305-7372(81)80011-4","article-title":"Radiotherapy for malignant melanoma: a re-appraisal","volume":"8","author":"Harwood","year":"1981","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"10.1016\/j.det.2025.03.013_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(06)70758-6","article-title":"Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma","volume":"7","author":"Stevens","year":"2006","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.det.2025.03.013_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/1740774511419684","article-title":"Collaborative ocular melanoma study randomized trial of I-125 brachytherapy","volume":"8","author":"Hawkins","year":"2011","journal-title":"Clin Trials"},{"issue":"1","key":"10.1016\/j.det.2025.03.013_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.suc.2019.09.010","article-title":"Role of radiation in the era of effective systemic therapy for melanoma","volume":"100","author":"Wernicke","year":"2020","journal-title":"Surg Clin North Am"},{"issue":"3","key":"10.1016\/j.det.2025.03.013_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0360-3016(91)90053-7","article-title":"Fraction size in external beam radiation therapy in the treatment of melanoma","volume":"20","author":"Sause","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.det.2025.03.013_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(15)00141-2","article-title":"Evolving treatment options for melanoma brain metastases","volume":"16","author":"Ajithkumar","year":"2015","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.det.2025.03.013_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/COC.0000000000000509","article-title":"Concurrent radiosurgery and immune checkpoint inhibition: improving regional intracranial control for patients with metastatic melanoma","volume":"42","author":"Murphy","year":"2019","journal-title":"Am J Clin Oncol"},{"issue":"12","key":"10.1016\/j.det.2025.03.013_bib15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s00066-018-1356-5","article-title":"Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters","volume":"194","author":"Schmidberger","year":"2018","journal-title":"Strahlenther Onkol"},{"issue":"9","key":"10.1016\/j.det.2025.03.013_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092653","article-title":"Robotic stereotactic radiosurgery in melanoma patients with brain metastases under simultaneous anti-PD-1 treatment","volume":"19","author":"Trommer-Nestler","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.det.2025.03.013_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000489948","article-title":"Gamma knife radiosurgery for metastatic brain tumors from malignant melanomas: a Japanese multi-institutional cooperative and retrospective cohort study (JLGK1501)","volume":"96","author":"Matsunaga","year":"2018","journal-title":"Stereotact Funct Neurosurg"},{"issue":"2","key":"10.1016\/j.det.2025.03.013_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.radonc.2018.06.017","article-title":"Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: patterns of care and treatment outcomes","volume":"128","author":"Gabani","year":"2018","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.det.2025.03.013_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11060-018-2880-y","article-title":"Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity","volume":"139","author":"Diao","year":"2018","journal-title":"J Neuro Oncol"},{"issue":"2","key":"10.1016\/j.det.2025.03.013_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11060-018-2795-7","article-title":"The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival, and toxicity","volume":"138","author":"Rahman","year":"2018","journal-title":"J Neuro Oncol"},{"issue":"2","key":"10.1016\/j.det.2025.03.013_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/CMR.0000000000000413","article-title":"Tolerance and outcomes of stereotactic radiosurgery combined with anti-programmed cell death-1 (pembrolizumab) for melanoma brain metastases","volume":"28","author":"Nardin","year":"2018","journal-title":"Melanoma Res"},{"issue":"2","key":"10.1016\/j.det.2025.03.013_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0360-3016(98)00021-2","article-title":"Radiotherapy for metastatic carcinomas of the kidney or melanomas: an analysis using palliative end points","volume":"41","author":"Huguenin","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.det.2025.03.013_bib23","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/1097-0142(197811)42:5<2206::AID-CNCR2820420518>3.0.CO;2-S","article-title":"Adjuvant radiation therapy for regional nodal metastases from malignant melanoma: a randomized, prospective study","volume":"42","author":"Creagan","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.det.2025.03.013_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(12)70138-9","article-title":"Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial","author":"Burmeister","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.det.2025.03.013_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.radonc.2006.10.001","article-title":"A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) study 96.06","volume":"81","author":"Burmeister","year":"2006","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.det.2025.03.013_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40425-019-0588-y","article-title":"Stereotactic radiosurgery combined with nivolumab or ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity","volume":"7","author":"Minniti","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.det.2025.03.013_bib27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000497211","article-title":"Combination of immunotherapy and brain radiotherapy in metastatic melanoma: a retrospective analysis","volume":"42","author":"Galli","year":"2019","journal-title":"Oncol Res Treat"},{"issue":"2","key":"10.1016\/j.det.2025.03.013_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/CMR.0000000000000542","article-title":"Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma","volume":"29","author":"Stera","year":"2019","journal-title":"Melanoma Res"},{"key":"10.1016\/j.det.2025.03.013_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2018.12.023","article-title":"Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases","volume":"110","author":"Rauschenberg","year":"2019","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.det.2025.03.013_bib30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2217\/imt-2018-0149","article-title":"Immunotherapy plus surgery\/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis","volume":"11","author":"Amaral","year":"2019","journal-title":"Immunotherapy"},{"issue":"11","key":"10.1016\/j.det.2025.03.013_bib31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.trecan.2016.09.007","article-title":"Immune priming of the tumor microenvironment by radiation","volume":"2","author":"Jiang","year":"2016","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.det.2025.03.013_bib32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ijc.28015","article-title":"Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer","volume":"133","author":"Vermeer","year":"2013","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.det.2025.03.013_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/jrr\/rrv007","article-title":"Carbon-ion beams induce production of an immune mediator protein, high mobility group box 1, at levels comparable with X-ray irradiation","volume":"56","author":"Yoshimoto","year":"2015","journal-title":"J Radiat Res"},{"issue":"5","key":"10.1016\/j.det.2025.03.013_bib34","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.20052494","article-title":"Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy","volume":"203","author":"Reits","year":"2006","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.det.2025.03.013_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.21037\/tlcr.2017.03.07","article-title":"Preclinical rationale for combining radiation therapy and immunotherapy beyond checkpoint inhibitors (i.e., CART)","volume":"6","author":"Flynn","year":"2017","journal-title":"Transl Lung Cancer Res"},{"issue":"7683","key":"10.1016\/j.det.2025.03.013_bib36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature24673","article-title":"Inactivation of DNA repair triggers neoantigen generation and impairs tumor growth","volume":"552","author":"Germano","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.det.2025.03.013_bib37","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"},{"issue":"24","key":"10.1016\/j.det.2025.03.013_bib38","doi-asserted-by":"crossref","first-page":"11687","DOI":"10.1158\/0008-5472.CAN-07-1406","article-title":"Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment","volume":"67","author":"Klopp","year":"2007","journal-title":"Cancer Res"},{"issue":"18 Pt 1","key":"10.1016\/j.det.2025.03.013_bib39","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1158\/1078-0432.CCR-07-1157","article-title":"Transforming growth factor-beta and the immune response: implications for anticancer therapy","volume":"13","author":"Wrzesinski","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.det.2025.03.013_bib41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.0303-6987.2005.00310.x","article-title":"The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma","volume":"32","author":"Barnhill","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.det.2025.03.013_bib42","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/1097-0142(19840515)53:10<2183::AID-CNCR2820531029>3.0.CO;2-9","article-title":"\u201cMicroscopic satellites\u201d are more highly associated with regional lymph node metastases than is primary melanoma thickness","volume":"53","author":"Harrist","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.det.2025.03.013_bib43","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaad.2011.04.031","article-title":"Guidelines of care for the management of primary cutaneous melanoma","volume":"65","author":"Bichakjian","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2025.03.013_bib44","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1067\/mjd.2001.117044","article-title":"Guidelines of care for primary cutaneous melanoma","volume":"45","author":"Sober","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2025.03.013_bib45","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1200\/JCO.2006.08.9755","article-title":"Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma","volume":"25","author":"Taylor","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.det.2025.03.013_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00008390-200506000-00005","article-title":"Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis","volume":"15","author":"Nagore","year":"2005","journal-title":"Melanoma Res"},{"key":"10.1016\/j.det.2025.03.013_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PAS.0b013e31820393ee","article-title":"Copy number variations and clinical outcome in atypical spitz tumors","volume":"35","author":"Raskin","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.det.2025.03.013_bib48","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaad.2015.01.009","article-title":"Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy","volume":"72","author":"Gerami","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2025.03.013_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/hed.10263","article-title":"Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma","volume":"25","author":"Vongtama","year":"2003","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.det.2025.03.013_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1445-2197.2008.04436.x","article-title":"Desmoplastic melanoma: the role of radiotherapy in improving local control","volume":"78","author":"Foote","year":"2008","journal-title":"ANZ J Surg"},{"issue":"10","key":"10.1016\/j.det.2025.03.013_bib51","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1002\/cncr.23895","article-title":"Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases","volume":"113","author":"Chen","year":"2008","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.det.2025.03.013_bib52","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/cncr.21311","article-title":"Wide excision without radiation for desmoplastic melanoma","volume":"104","author":"Arora","year":"2005","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.det.2025.03.013_bib53","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1600-0560.2011.01704.x","article-title":"Incidence and survival of desmoplastic melanoma in the United States, 1992-2007","volume":"38","author":"Feng","year":"2011","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.det.2025.03.013_bib54","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jso.21778","article-title":"Desmoplastic melanoma\u2014the step-child in the melanoma family?","volume":"103","author":"Wasif","year":"2011","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.det.2025.03.013_bib55","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000254133","article-title":"Provisional results of treatment of the m\u00e9lanose pr\u00e9canc\u00e9reuse circonscrite Dubreuilh by Bucky-rays","volume":"136","author":"De Groot","year":"1968","journal-title":"Dermatologica (Basel)"},{"issue":"6","key":"10.1016\/j.det.2025.03.013_bib56","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1046\/j.1365-2133.2002.04750.x","article-title":"A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays","volume":"146","author":"Farshad","year":"2002","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2025.03.013_bib57","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1067\/mjd.2000.106241","article-title":"Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients","volume":"43","author":"Schmid-Wendtner","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2025.03.013_bib58","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archderm.1976.01630300015002","article-title":"Treatment of melanotic freckle with x-rays","volume":"112","author":"Kopf","year":"1976","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.det.2025.03.013_bib59","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/archderm.1994.01690080074010","article-title":"Lentigo maligna of the head and neck: results of treatment by radiotherapy","volume":"130","author":"Tsang","year":"1994","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.det.2025.03.013_bib60","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1001\/archfaci.2011.66","article-title":"Carbon dioxide laser treatment for lentigo maligna: a retrospective review comparing 3 different treatment modalities","volume":"13","author":"Lee","year":"2011","journal-title":"Arch Facial Plast Surg"},{"issue":"3","key":"10.1016\/j.det.2025.03.013_bib61","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1440-1673.1996.tb00413.x","article-title":"Radiotherapy for melanotic freckles","volume":"40","author":"Christie","year":"1996","journal-title":"Australas Radiol"},{"issue":"6","key":"10.1016\/j.det.2025.03.013_bib62","first-page":"285","article-title":"Patients\u2019 perceptions of their cosmetic appearance more than ten years after radiotherapy for basal cell carcinoma","volume":"6","author":"Cooper","year":"1988","journal-title":"Radiat Med"},{"issue":"4","key":"10.1016\/j.det.2025.03.013_bib63","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2133.2003.05155.x","article-title":"Local recurrence in melanoma in situ: influence of sex, age, site of involvement and therapeutic modalities","volume":"148","author":"Zalaudek","year":"2003","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.det.2025.03.013_bib64","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.clon.2010.06.013","article-title":"A review of the clinical evidence for intensity-modulated radiotherapy","volume":"22","author":"Staffurth","year":"2010","journal-title":"Clin Oncol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863525000282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863525000282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T21:44:53Z","timestamp":1750974293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863525000282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0733863525000282"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2025.03.013","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy for Metastatic Melanoma","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2025.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}